1 / 27

Clinically Significant Drug Interactions

Clinically Significant Drug Interactions. Drug Interaction Definition. A clinically meaningful alteration in the effect of one drug as a result of coadministration of another Drug affected by interaction is called the “object drug” Drug causing interaction is called the “precipitant drug”

lew
Download Presentation

Clinically Significant Drug Interactions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinically Significant Drug Interactions

  2. Drug Interaction Definition • A clinically meaningful alteration in the effect of one drug as a result of coadministration of another • Drug affected by interaction is called the “object drug” • Drug causing interaction is called the “precipitant drug” • Interactions may be desirable or undesirable

  3. Types of Drug Interactions • Drug-drug • Drug-disease • Drug-herbal • Drug-alcohol • Drug-food • Drug-nutritional status • Drug-lab

  4. Mechanisms of Drug Interactions • Pharmacokinetic interactions • Percipitant drug affects the absorption, distribution, metabolism, or excretion of object drug • Pharmacodynamic interactions • Effect of object drug is modified by the precipitant without changes in pharmacokinetics of object drug

  5. Pharmacokinetic Drug Interactions • Inhibition of Absorption

  6. Pharmacokinetic Drug Interactions • Distribution

  7. Pharmacokinetic Drug Interactions • Metabolism • Enzymes associated with drug metabolism are called cytochrome P450 enzymes • ‘’cytochrome’’ is derived from color of liver cells (dark red) attributed to iron content of the enzymes • P450 refers to ultraviolet light wavelength absorbed by enzymes

  8. Pharmacokinetic Drug Interactions • Metabolism • Cytochrome P450 nomenclature CYP3A4 CYP Human cytochrome P450 3 Family A Subfamily 4 Gene • Enzymes belonging to the 3A and 2D subfamilies account for most of the well-identified drug interactions

  9. Pharmacokinetic Drug Interactions • Metabolism • Drugs that undergo hepatic biotransformation are frequently substrates for the same enzymes • While requiring these enzymes for their own metabolism, they also may induce or inhibit enzyme activity on other drugs taken concurrently

  10. Pharmacokinetic Drug Interactions • Metabolism

  11. Pharmacokinetic Drug Interactions • Metabolism

  12. Pharmacokinetic Drug Interactions • Elimination • Altered Renal Elimination • For some drugs, active secretion into the renal tubules is an important route of elimination • Example • Digoxin is eliminated primarily through renal excretion, and drugs such as amiodarone, clarithromycin, itraconazole can inhibit this process. Digoxin toxicity may result.

  13. P-Glycoprotein • P-glycoprotein is a transporter found in the liver, intestine, kidney, and brain • P-glycoprotein acts as an efflux pump to pump toxic materials out of the cell • Example • Digoxin, a PGP substrate • Quinidine is a PGP inhibitor. It inhibits expulsion of digoxin back into intestine, so increases digoxin concentrations • Rifampicin stimulates PGP and so decreases serum digoxin

  14. P-Glycoprotein • In the kidney there is a similar effect with PGP enhancing clearance of substances • Quinidine and cyclosporine inhibit PGP, so clearance of digoxin is inhibited • In the CNS, PGP inhibits the passage of some medicines across the blood–brain barrier, e.g. loperamide • A PGP inhibitor allows greater passage across the blood–brain barrier

  15. Pharmacodynamic Drug Interactions • Additive Pharmacodynamic Effects • When two or more drugs with similar pharmacodynamic effects are given, additive effects may result in excessive response and toxicity • Examples • Combining ACEI with potassium-sparing diuretics results in augmented hyperkalemia • Combining a diuretic with a beta blocker provides a greater reduction in blood pressure than either can impart alone

  16. Pharmacodynamic Drug Interactions • Antagonistic Pharmacodynamic Effects • Drugs with opposing pharmacodynamic effects may reduce the response to one or both drugs • Example • NSAIDs may inhibit the antihypertensive effect of ACEI • Reduction in the synthesis of the vasodilating renal prostaglandins

  17. Drug Interaction Risk Factors • Patient Factors • Number of medications (polypharmacy) • Severity of the diseases being treated • Age (the very young and elderly) • Renal and hepatic dysfunction • Acute medical condition (eg, dehydration, infection) • Pharmacogenetics

  18. Drug Interaction Risk Factors • Drug Factors • Higher dose • Narrow therapeutic range (e.g.digoxin) • NSAIDs • Anticoagulants • Hypoglycemics • Antiarrythmics • Anticonvulsants • Antibiotics • Antiretrovirals

  19. Drug Interaction Risk Factors • Other Considerations • Increasing use of prescription drugs • Increasing complexity of medication regimens • Fragmented health care system • Incomplete problem or med lists • Multiple prescribers managing • Multiple pharmacies dispensing • Self-medication with OTC, herbals

  20. Relevance of Drug Interactions • Impossible to memorize all drug interactions (2500 drug pairs) • Most potential drug interactions never lead to actual clinical effect • Necessary to determine which drug interactions are most clinically important • Ones most likely to cause harm if not detected

  21. Drug Interaction Resources • Print & Electronic Resources • Micromedex • Lexicomp • Facts and Comparisons • Hansten and Horn’s The Top 100 Drug Interactions • Stockley's Drug Interactions • Websites • Drug Interaction Checker (Medscape) • Drug Interaction Checker (Drugs.com)

  22. Managing Drug Interactions • Comprehensive medication review • Identify potential drug interactions • Assess clinical significance • Continue/discontinue/substitute • Monitor and follow-up • Document • Communicate with patient & healthcare professionals

  23. Managing Drug InteractionsTips for Pharmacists • Learn to recognize factors that alter a patient’s risk for an adverse event when exposed to interacting drug pairs • Consider the risk of the potential interaction against the benefit of administering the drugs • If the risk to patient appears to be greater than expected benefit, identify a suitable alternative

  24. Managing Drug InteractionsTips for Pharmacists • Drug interaction classification systems should be used for general guidance • No book, PDA, or computer based classification system can replace pharmacist’s informed evaluation • Regard each interaction– patient pair as unique

  25. Case Study-1 • A 23 y/o woman with a seizure disorder & diabetes is being admitted with ataxia and tremors. She was initiated on Bactrim 10 days ago for UTI. Her Phenytoin level is 28. Her current medication list includes: • Sulfamethoxazole/trimethoprim DS 1 tab poBID • Phenytoin 400 mg po QD • Lantus 15 units SQ q HS • Novolog 5 units SQ with each meal • What actual drug-drug interaction(s) do you identify? • Could it have been prevented? What will you recommend?

  26. Case Study-2 • A 75 y/o woman with hypertension and atrial fibrillation is prescribed levofloxacin for community acquired pneumonia. Her other medications include: • Sotalol 80 mg PO BID • Aspirin 81 mg PO QD • Enalapril 20 mg PO BID • HCTZ 50 mg PO QD • Felodipine 5mg PO QD • What potential drug-drug interaction(s) do you identify? • What will you recommend?

More Related